Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Change in Cash (2022 - 2025)

Bioregenx has reported Change in Cash over the past 4 years, most recently at $22436.0 for Q4 2025.

  • For Q4 2025, Change in Cash rose 292.14% year-over-year to $22436.0; the TTM value through Dec 2025 reached $10979.0, up 116.39%, while the annual FY2025 figure was $10979.0, 116.39% up from the prior year.
  • Change in Cash for Q4 2025 was $22436.0 at Bioregenx, up from $491.0 in the prior quarter.
  • Over five years, Change in Cash peaked at $67439.0 in Q4 2023 and troughed at -$224118.0 in Q2 2023.
  • A 4-year average of -$35687.2 and a median of -$6279.5 in 2022 define the central range for Change in Cash.
  • On a YoY basis, Change in Cash climbed as much as 7896.42% in 2023 and fell as far as 28655.33% in 2023.
  • Year by year, Change in Cash stood at -$865.0 in 2022, then soared by 7896.42% to $67439.0 in 2023, then tumbled by 117.31% to -$11677.0 in 2024, then surged by 292.14% to $22436.0 in 2025.
  • Business Quant data shows Change in Cash for BRGX at $22436.0 in Q4 2025, $491.0 in Q3 2025, and -$37169.0 in Q2 2025.